Great Plains Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• Novel TEER System Safe, Effective For High-Risk Primary MR Patients
  For high-risk patients with primary mitral valve regurgitation (MR), the novel Neonova transcatheter edge-to-edge repair (TEER) system was safe and effective, with a high rate of event-free survival and sustained clinical and echocardiographic improvements through two years, according to a prospective study published June 29 in JACC: Asia.
• Joint Society Editorial Calls For Science-Based Approach to CV Health Equity
  A joint editorial on behalf of the ACC, American Heart Association, European Society of Cardiology and World Heart Federation calls for a new era of equity-centered cardiovascular care designed to redefine prevention, optimize care delivery and ensure that all patients worldwide benefit equally from the promise of modern cardiovascular medicine.
• SHaRe Registry Identifies MACE Predictors in Mild HCM
  About one in five patients with phenotypically mild hypertrophic cardiomyopathy (HCM) experienced major adverse cardiovascular events (MACE) over seven years of follow-up, according to SHaRe Registry research published July 8 in JACC.
• PFA Matches RFA on PVI Durability, Shows Low AE Rates in Registry Data
  Two studies published in JACC: Clinical Electrophysiology on June 29 provide new insights on the durability of pulmonary vein isolation (PVI) with pulsed field ablation (PFA) vs. radiofrequency ablation (RFA) in patients with persistent atrial fibrillation (AFib), as well as the safety profile of PFA among patients undergoing their first ablation for AFib.
• Eagle’s Eye View: Can Sugar-Sweetened Beverages and Fruit Juice Lead to Hypertension?
  In this week’s View, Dr. Eagle looks at withdrawing guideline-directed medical therapy (GDMT) for patients with atrial fibrillation (AF).